1 min read
AptarGroup Forecasts Q4 Adjusted EPS of $1.39 to $1.47 Per Share
The company expects the emergency-medicine destocking impact to be behind it in Q4. Management expects Pharma to drive a strong year-end finish and forecasts year-over-year margin improvement.

AptarGroup, Inc. forecast fourth-quarter adjusted earnings per share of $1.39 to $1.47, while expecting emergency-medicine destocking’s impact to be behind the company during the quarter.
The company expects Pharma to drive a strong finish to the year and forecasts year-over-year margin improvement. Management cited productivity and operational efficiencies.
AptarGroup expects clearer visibility by Q1 2027 and remains comfortable with a long-term Pharma growth corridor of 7% to 11%.